---------------------------------
The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System. |
---------------------------------
---------------------------------
Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information
---------------------------------
 |
 |
 Pharmacist e-Link CE Spotlight |
 |
 |
The Pharmacist's Role in the Medication Therapy Management of Chronic Pain
Managing your patients with chronic pain is critical to ensuring the best patient outcomes. This session will bring you vital information you need to know to give these pharmacy patients the best possible care and greatly improve their quality of life.
This program is supported by an educational grant from Purdue Pharma L.P. |
 |
Counseling Patients on the Use of Pancreatic Exocrine Insuffiency (PEI) Drug Products: An Update
Pancreatic extract drug products are indicated in the treatment of exocrine pancreatic insufficiency, a potential complicating factor in cystic fibrosis, chronic pancreatitis, pancreatic tumors, or pancreatectomy. The safe and effective use of pancreatic enzyme drug products requires standardized enzyme activity and consistent drug therapy. The pharmacist must be aware of risks in generic substitution and therapeutic interchange to properly counsel patients and work with other members of the healthcare team.
Commercial Support Provided by Solvay Pharmaceuticals, Inc. |
|
 |
The Vitamin D and Calcium Crisis: Strategies to Improve Bone Health
The goal of this educational strategy is to increase attention and understanding of the role of nutrition, calcium and vitamin D in bone health in order to prevent and reduce bone disease and promote evidence-based information to encourage these changes.
Supporting Organizations: Merck & Co., Inc. and Pharmavite |
 |
Opportunities and Guidelines for Aggressive Prevention of Secondary Stroke
This 1-hour audio lecture activity, including a patient case study review, is hosted by Dr. Howard Kirshner from Vanderbilt Stroke Center and Dr. Michael Bottorff from the University of Cincinnati. This activity is designed to provide hospital pharmacists and managed markets physicians with education on the burden of primary and secondary stroke and the importance of early and aggressive stroke prevention in the hospital setting.
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
|
 |
Understanding ADHD Care for Children: HEDIS® and Beyond
Attention-deficit/hyperactivity disorder (ADHD) is one of the more common chronic conditions of childhood. Children with ADHD may experience significant functional problems such as school difficulties, academic underachievement, troublesome relationships with family members and peers, and behavioral problems. To drive care improvement in ADHD and reinforce the use of clinical guidelines and recommendations for disease management to improve patient outcomes and reduce the overall clinical and economic burden, NCQA developed and approved a HEDIS 2006 performance measure that assesses appropriate follow-up care for children prescribed an ADHD medication. First year reports for that measure are now available, and point toward a need for significant improvement.
This program is supported through educational grants from Eli Lilly and Company and McNeil Pediatrics Division of McNeil-PPC, Inc. |
 |
The Safety of COX-2 Pharmacotherapy for Patients in Pain
There are anecdotal reports about the COX-2 inhibitors of improved efficacy
over the traditional NSAIDs. This program will help the practitioner identify those patients with specific risk factors, in whom the risks would outweigh potential benefits, and properly educate those for whom COX-2 use is still an option.
This program is supported by an educational grant from Pfizer Inc. |
 |
Emerging Trends in HIV Combination Therapy: The Pharmacology and the Pharmacist
Because of their unique accessibility and extensive knowledge about medications, pharmacists fulfill a major role in ensuring that patients with HIV/AIDS understand and properly take their medicines, non-compliance with therapeutic regimens remains a particularly significant challenge in this patient population. Pharmacists are in an excellent position to provide compliance counseling at the point-of-care, as well as to monitor continued compliance over time, including, if necessary, notifying prescribers about potential therapy problems.
The program is supported by an educational grant from Roche Laboratories. |
 |
Overcoming "Insulin Resistance": A Practical Approach to Initiating Insulin Therapy
The goal of the symposium is to educate clinical endocrinologists about practical issues relating to the management of patients with diabetes. The content will include a practical and insulin-focused approach to managing patients with type 2 diabetes. The case discussions will weave together the themes of socioeconomic issues in diabetes care; pediatric, adult, and aging patient scenarios; diabetes therapy; comorbidity factors; as well as coding dilemmas and solutions.
This program is sponsored by the American Association of Clinical Endocrinologists (AACE) and supported by an educational grant from Novo Nordisk Inc.
|
 |
Common Misconceptions with Bioequivalence and Interchangeability
This CE program examines the bioequivalence and interchangeability of drugs. Since several factors can influence the bioavailability of drugs, this activity highlights instances where sub-therapeutic responses, alterations in outcomes, or adverse events can be consequences of pharmacokinetic interactions.
This program is co-sponsored by ArcMesa Educators and Scinexa, LLC.
|
 |
AAFP Case Study: COPD: Putting Guidelines into Practice
Research has shown that the diagnosis and treatment of COPD can be improved in primary care. A recent study in the journal Preventive Medicine (March 2005) concluded that although primary care providers manage asthma patients using asthma guidelines, a great proportion of COPD patients are under-treated, mainly in the primary stages of the disease. The study concluded that there is a need for better implementation of COPD guidelines by primary care providers and a need for COPD to be diagnosed in its early stages.
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc.
|
|
|
